Early elevation of cardiac troponin I is predictive of short-term outcome in neonates and infants with coronary anomalies or reduced ventricular mass undergoing cardiac surgery  by Bojan, Mirela et al.
Perioperative Management Bojan et al
P
MEarly elevation of cardiac troponin I is predictive of short-term
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1436Objective: The present study aimed to assess the usefulness of routine monitoring of cardiac troponin I concen-
trations within 24 hours of surgery (cTn-I<24h) in neonates and infants undergoing cardiac surgery.
Methods: The added predictive ability of a high peak cTn-I<24h (within the upper quintile per procedure) for
a composite outcome, including 30-day mortality and severe morbidity, was assessed retrospectively. The pre-
dicted risk for the composite outcomewas estimated from a logistic regression model including preoperative and
intraoperative variables. Adding a high peak cTn-I<24h to the risk model resulted in reclassification of the pre-
dicted risk. It also allowed quantification of the improvement in reclassification and discrimination by the dif-
ference between c-indexes, the Net Reclassification and the Integrated Discrimination Indexes (NRI and IDI).
Results:Overall, 1023 consecutive patients were included. Adding a high peak cTn-I<24h to the model resulted
in no improvement in reclassification or discrimination in the overall population (difference between c-indexes:
0.011 [0.004 to 0.029], NRI¼ 0.06, P¼ .22, IDI¼ 0.02, P¼ .06), except in a subgroup of patients undergoing
the arterial switch operation with or without ventricular septal defect closure and/or aortic arc repair, anomalous
origin of the left coronary artery from the pulmonary artery repair, truncus arteriosus repair, Norwood procedure,
and Sano modification, in whom NRI ¼ 0.23 (P ¼ .005) and IDI ¼ 0.05 (P<.001).
Conclusions: Patients with coronary anomalies and patients with reduced ventricular mass should benefit from
the routine monitoring of cTn-I concentrations after surgery for congenital cardiac disease. (J Thorac Cardiovasc
Surg 2012;144:1436-44)Myocardial damage is a major determinant of postoperative
cardiac dysfunction associated with morbidity and mortal-
ity after cardiac surgery. Cardiac troponins are highly sensi-
tive and specific markers of myocardial damage and have
evolved as the gold standard for the diagnosis of myocardial
infarction.1 They are well documented to predict clinical
outcome after cardiac surgery in adults.2-7 Several authors
have suggested prognostic implications of troponin
concentrations measured early in children undergoing
cardiac surgery.8-17 However, troponin release after
surgery for congenital cardiac disease is multifactorial
and depends on the type of procedure being performed.
Overall, pediatric literature on this topic has included
small samples and various case mixes, rendering
conclusions difficult to draw. The present study aimed toe Anesthesia and Critical Care Department,a the Biochemistry Department,b
e Pediatric Cardiac Surgery Department,c Necker-Enfants Malades Hospital,
tance Publique, Ho^pitaux de Paris; and the Paris Descartes University,d
l of Medicine, Paris, France.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Nov 15, 2011; revisions received March 4, 2012; accepted
blication May 15, 2012; available ahead of print June 18, 2012.
for reprints: Mirela Bojan, MD, MSc, Anesthesia and Critical Care Depart-
Necker-Enfants Malades Hospital, 149, rue de Sevres, 75015 Paris, France
il: mirela.bojan@nck.aphp.fr).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2012.05.034
The Journal of Thoracic and Cardiovascular Surassess the predictive ability of cardiac troponin I (cTn-I)
for short-term outcome in a large cohort of consecutive ne-
onates and infants undergoing cardiac surgery in a tertiary
referral cardiothoracic surgical center and to identify proce-
dures in which serial measurements of cTn-I provide clini-
cal usefulness.
PATIENTS AND METHODS
The project was reviewed and approved by the Ethics Committee of the
French Society of Thoracic and Cardiovascular Surgery, Paris, France,
which waived the need for parental consent to the use of records made
anonymous for this research.
Study Population
This retrospective study included all consecutive neonates and infants
who underwent surgery for congenital heart disease from January 2007
through June 2010 at the Necker-Enfants Malades University Hospital,
Paris, France, and relied on a database storing all of their preoperative, in-
traoperative, and postoperative data. Owing to an extensive French policy
of prenatal detection and abortion in cases of hypoplastic left heart syn-
drome (HLHS), few patients had HLHS procedures during the study pe-
riod. Surgical complexity was accounted for by the Aristotle Basic
Complexity score.18
Surgical Management
Patients underwent surgery with normothermic or mildly hypothermic
cardiopulmonary bypass (CPB) or deep hypothermic circulatory arrest
with selective cerebral perfusion when requiring aortic arch repair. Myo-
cardial protection was achieved with intermittent blood cardioplegia atgery c December 2012
Abbreviations and Acronyms
ALCAPA ¼ anomalous origin of the left coronary
artery from the pulmonary artery
ASO ¼ arterial switch operation
cTn-I ¼ cardiac troponin I
cTn-I<24h ¼ cardiac troponin I concentrations
within 24 hours of surgery
CPB ¼ cardiopulmonary bypass
ECMO ¼ extracorporeal membrane
oxygenation
HLHS ¼ hypoplastic left heart syndrome
ICU ¼ intensive care unit
IDI ¼ Integrated Discrimination
Improvement
LOS ¼ length of stay
NRI ¼ Net Reclassification Improvement
TAPVC ¼ total anomalous pulmonary vein
connection
VSD ¼ ventricular septal defect
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Mthe same temperature as the CPB perfusate, as described previously.19
When the aorta was not opened, the cardioplegic solution was administered
in the ascending aorta and repeated every 10 minutes in normothermia.
When aortic opening was necessary, such as during the arterial switch op-
eration (ASO), repair of the anomalous origin of the left coronary artery
from the pulmonary artery (ALCAPA), or repair of truncus arteriosus, car-
dioplegic solution was first delivered into the ascending aorta and subse-
quently directly into the coronary ostia.
Surgical procedures were performed with standard or previously de-
scribed techniques.20-22 Most ventricular septal defects (VSDs) were
closed through the right atrium. Repair of tetralogy of Fallot used
a transatrial–transpulmonary approach. The ASO was performed using
the Lecompte maneuver and standard coronary transfer. Complete
atrioventricular canal was repaired with the 2-patch technique. During
truncus arteriosus repair, the pulmonary outflow tract was reconstructed
with either a valved conduit or autologous tissue. Patients with ALCAPA
underwent aortic reimplantation of the anomalous artery. Coarctation
was repaired with extended end-to-end anastomosis. Few patients with se-
vere hemodynamic instability, requiring the modified Blalock-Taussig
shunt, underwent the procedure with CPB. Only few bidirectional cavopul-
monary shunts were performed with an inert shunt, and most of them were
performedwith CPB. The classic Norwood procedure or Sanomodification
was performed for palliation of HLHS.
Troponin Concentration Measurement
Only cTn-I concentrations were measured during the study period, as
independent of renal function.11 The cTn-I concentrations were measured
before surgery, at 20 minutes after unclamping, at admittance in the inten-
sive care unit (ICU), every 6 hours on day 0, and every 6 to 12 hours there-
after. Blood samples were assayed for cTn-I with an immunometric
technique on the Vitros ECi Immunodiagnostics System (Ortho-Clinical
Diagnostics, Rochester, NY). The detection limit was 0.01 mg $ L1.
Short-Term Outcome
Because of the low mortality rate, a composite variable was defined as
the occurrence of death within 30 days of surgery and/or severe postoper-
ative morbidity. Severe morbidity was accounted for by events that haveThe Journal of Thoracic and Carbeen shown previously to be associated with early mortality: an extremely
low cardiac output necessitating extracorporeal membrane oxygenation
(ECMO)23 and/or leading to severe renal injury necessitating dialysis (peri-
toneal in the present population)24 and/or a very long length of stay (LOS)
in the ICU.25 Because LOS depends on surgical complexity, and in an at-
tempt to standardize the LOS of all patients on the same scale, a specific
threshold for a very long LOS was defined in each procedure by its 95th
percentile.26
Statistical Analysis
Concentrations of cTn-I measured within 6 to 24 hours of surgery have
been shown to provide the best predictive ability for short-term outcome in
both children and adults.4,5,16 The ability of the peak cTn-I within 24 hours
of surgery (cTn-I<24h) to predict the composite outcome was assessed vi-
sually by plotting all of the cTn-I concentrations recorded during the first
week in patients meeting the composite outcome and in the others
(Figures 1 and 2) and then by comparing the mean peak cTn-I<24h concen-
trations with the Wilcoxon rank test (Table 1). To standardize all measure-
ments on the same scale and according to a previous publication,2 we
defined a high peak cTn-I<24h by the upper quintile of all peak cTn-I<24h
concentrations measured in similar procedures, and then we calculated its
sensitivity, specificity, and likelihood ratio for the composite outcome. The
likelihood ratio of a screening test summarizes howmany timesmore likely
patients with disease are to have a positive result; it is considered to provide
strong evidence to rule in diagnoses when greater than 10 and to rule out
diagnoses when less than 0.1.27
Preoperative and intraoperative characteristics available in the database
were compared between patients meeting the composite outcome and the
others. These characteristics were used as predictors of the composite out-
come in a logistic regression model (the non-T model) if a significant dif-
ference was noted (P<.10). The predicted risk was further estimated from
a second model, including in addition the high peak cTn-I<24h as a predic-
tor (the T model). Discrimination of each model was assessed by the c-in-
dex, and the improvement in discrimination was quantified by the
difference between c-indexes, with 95% confidence interval estimated
from bootstrapping with 1000 resamples.
New indexes have been shown to provide information about the useful-
ness of a biomarker: the Net Reclassification Improvement (NRI) and the
Integrated Discrimination Improvement (IDI).28 For this purpose, the pre-
dicted risk was estimated according to each model and stratified into 4 risk
categories: less than 5%, 5% to 15%, 15% to 30%, and more than 30%. It
allowed us to cross-classify the predicted risks, to compare the predicted
versus observed risks, and to identify subjects who changed their risk cat-
egory after adding the high peak cTn-I<24h to the model.29 The NRI is the
difference in the proportion of improvements in reclassification (when a pa-
tient meeting the outcome moves up a risk category and a patient not meet-
ing the outcome moves down) and the proportion of worse reclassification
(when a patient meeting the outcome moves down a risk category and a pa-
tient not meeting the outcome moves up). This index has been criticized
because it requires andmay be affected by the choice of predefined risk cat-
egories28; therefore, the IDI, which has been proposed as a continuous ver-
sion of NRI, was also calculated. The R statistical package (www.r-project.
org) was used for all analyses.RESULTS
Overall, 1269 patients less than 1 year old underwent car-
diac surgery from January 1, 2007, through June 30, 2010,
and were enrolled retrospectively. They had undergone 65
different procedures. Overall, 995 (78.4%) patients under-
went surgery with CPB; the mean duration of CPB was
102.5 65.8 minutes and ranged between 49.5 14.5 min-
utes in aortic valvuloplasty and 199.9  89.9 minutes indiovascular Surgery c Volume 144, Number 6 1437
FIGURE 1. Cardiac troponin I concentrations measured within the first week of surgery in patients with cardiopulmonary bypass. The composite outcome
included 30-day mortality and severe morbidity. Severe morbidity was accounted for by an extremely low cardiac output necessitating extracorporeal mem-
brane oxygenation and/or leading to renal injury requiring peritoneal dialysis, and/or by a very long length of intensive care unit stay (the 95th percentile per
procedure). Mean values are shown using the LOESS (locally weighted scatterplot smoother). Shading lines show the first 24 hours after surgery. VSD,
Ventricular septal defect; ASO, arterial switch operation; HLHS, hypoplastic left heart syndrome; TAPVC, total anomalous pulmonary venous connection;
ALCAPA, anomalous left coronary artery from the pulmonary artery.
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FIGURE 2. Cardiac troponin I concentrations measured within the first week after surgery in patients without cardiopulmonary bypass. The composite
outcome included 30-day mortality and severe morbidity. Severe morbidity was accounted for by an extremely low cardiac output necessitating extracor-
poreal membrane oxygenation and/or leading to renal injury requiring peritoneal dialysis, and/or by a very long length of stay in the intensive care unit (the
95th percentile per procedure). Mean values are shown using the LOESS (locally weighted scatterplot smoother). Shading lines show the first 24 hours after
surgery.
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was 63.0  24.5 minutes and ranged between 21.3  7.1
minutes in aortic valvuloplasty and 96.5  20.4 minutes
in truncus arteriosus repair. A total of 164 (12.9%) patients
had delayed sternal closure, 16 (1.3%) required ECMO,
and 90 (7.1%) required peritoneal dialysis. The 30-day
mortality rate was 4.6%. The most prevalent proceduresThe Journal of Thoracic and Car(15 cases/procedure) are shown in Table 1. Among
the 83 patients who underwent ASO plus VSD closure,
17 had concomitant aortic arch repair. Overall, 23
patients had obstructed total anomalous pulmonary vein
connection (TAPVC) and 20 patients had nonobstructed
TAPVC: all deaths occurred in the obstructed group. The
pulmonary outflow tract was reconstructed with a valveddiovascular Surgery c Volume 144, Number 6 1439
TABLE 1. Characteristics of the study population and diagnostic accuracy of an early peak of cardiac troponin I for a composite outcome defined
as 30-day mortality and/or severe postoperative morbidity
Procedures
(no. of patients)
Characteristics of the study population
Comparison of cTn-I<24h
(mg $ L1 mean, SD) between
groups according to the
occurrence of the
composite outcome
Diagnostic accuracy
of a ‘‘high peak
cTn-I<24h’’* for the
composite outcome
Age (d),
mean, SD
Length of ICU
stay (d), median, IQR
and 95th percentile
Thirty-day
mortality,
n (%)
No. with the
composite
outcome,
n (%) No Yes
P
value
Threshold for
a high peak
cTn-I<24h* Se Sp
Likelihood
ratio
VSD repair (200) 139.8, 69.1 3, 2-6, 14.5 3 (1.5) 13 (6.5) 17.5, 13.7 20.2, 16.9 .94 24.3 30.8 80.8 1.60
Tetralogy of Fallot
repair (149)
149.7, 61.1 3.5, 2-4, 7.6 0 8 (5.4) 32.7, 26.5 30.9, 24.0 .91 51.8 25.0 80.0 1.25
ASO (116) 7.4, 7.2 4, 3-6, 10 2 (1.7) 11 (9.6) 8.1, 4.7 23.0, 18.1 .003 13.1 63.6 84.5 4.10
Coarctation
repair (141)
29.3, 44.7 3, 2-6, 13 0 7 (5.0) 0.4, 1.3 0.2, 0.2 .60 0.4 20.0 80.3 1.01
ASOþVSD  aortic
arch repair (83)
30.7, 65.6 6, 4-8, 16.8 2 (2.4) 17 (20.2) 16.2, 10.8 34.7, 32.4 .02 28.1 47.1 86.4 3.46
CAVC repair (71) 141.9, 71.1 6, 4-11.5, 22.5 1 (1.4) 5 (7.0) 41.4, 27.1 19.82 10.47 .05 55.4 0 78.8 0
PA banding (64) 53.5, 48.8 6, 3-9, 40 5 (7.8) 8 (12.5) 1.9, 4.2 4.0, 7.0 .45 2.2 28.6 81.5 1.54
MBT shunt (31) 35.5, 36.2 4, 3-7, 11 2 (6.4) 5 (16.1) 0.8, 1.2 1.1, 1.1 .55 1.1 40.0 84.6 2.60
Obstructed (23)
and nonobstructed
(20) TAPVC
45.0, 54.6 6, 3-13, 44.4 6 (13.9) 14 (32.5) 20.9, 17.9 20.8, 16.0 .93 38.6 30.8 82.7 1.78
Aortic arch
repair (40)
43.2, 66.1 9, 5.7-13, 34.2 3 (7.5) 14 (35.0) 12.9, 9.4 18.1, 10.6 .14 22.6 28.6 84.6 1.86
Bidirectional
cavopulmonary
anastomosis (30)
211.1, 83.4 3, 2-5, 12.5 0 3 (10.0) 3.7, 3.2 5.6, 2.4 .17 6.1 33.3 81.5 1.80
Aortic
valvuloplasty (27)
42.5, 58.3 4, 3-6, 19.4 2 (7.4) 5 (18.5) 4.2, 3.3 3.3, 3.1 .56 7.0 20.0 77.3 0.88
HLHS procedure (17) 7.4, 6.7 13, 7-15, 48.8 10 (58.8) 15 (88.2) 9.5, 0.2 17.6, 10.0 .37 21.9 26.6 100.0 >10
Truncus arterious
repair (17)
28.3, 13.2 10, 9-15, 20.4 4 (23.5) 7 (41.2) 28.3, 10.3 53.3, 27.5 .10 60.1 57.1 100.0 >10
ALCAPA repair (15) 105.5, 48.3 14, 11.7-14, 20.8 0 4 (26.7) 8.0, 4.7 16.2, 8.7 .05 14.8 50.0 90.9 5.49
Severe morbidity was accounted for by an extremely low cardiac output requiring extracorporeal membrane oxygenation and/or leading to renal injury requiring peritoneal di-
alysis, and/or by a very long length of ICU stay (the 95th percentile per procedure). SD, Standard deviation; ICU, intensive care unit; IQR, interquartile range; cTN-I<24h, cardiac
troponin I concentrations within 24 hours of surgery; Se, sensitivity; Sp, specificity; VSD, ventricular septal defect; CAVC, complete atrioventricular canal; PA, pulmonary artery;
MBT,modified Blalock-Taussig;ASO, arterial switch operation; TAPVC, total anomalous pulmonary venous connection;HLHS, hypoplastic left heart syndrome; ALCAPA, anom-
alous left coronary artery from the pulmonary artery. *Upper quintile of all peak troponin I concentrations measured within 24 hours per procedure.
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undergoing truncus arteriosus repair. Only 31 of 47 modi-
fied Blalock-Taussig shunts were performed without CPB
and analyzed here. Overall, 30 of the 37 bidirectional cav-
opulmonary anastomoses were performed with CPB and
analyzed here.
Results of the cTn-I Analysis
Overall, 11,705 cTn-I concentrations measured within
the first week after surgery were available, mean 9.2 mea-
surements per patient, ranging between 3.6 in patients
with coarctation repair and 15.7 in patients with HLHS pro-
cedures. Analysis was restricted to 9502 cTn-I measure-
ments performed in 1023 patients who had undergone the
most prevalent procedures. Patients with ASO plus VSD
closure and patients with concomitant aortic arch repair1440 The Journal of Thoracic and Cardiovascular Surwere combined for analysis, inasmuch as their mean
peak cTn-I<24h values were not statistically different:
20.9 20.7 mg $ L1 and 17.4 10.4 mg $ L1, respectively
(P ¼ .39). Similarly, patients with obstructed and unob-
structed TAPVC repair were combined for analysis, with
peak cTn-I<24h of 20.8  20.0 mg $ L1 and 21.0  14.8
mg $ L1, respectively (P ¼ .67) and patients undergoing
the Norwood procedure and Sano modification, with peak
cTn-I<24h of 14.5  7.6 mg $ L1 and 19.8  12.2 mg $
L1, respectively (P ¼ .47). Patients undergoing modified
Blalock-Taussig shunts performed without CPB (n ¼ 31)
had significantly lower cTn-I<24h than those requiring
CPB (n ¼ 16): 0.9  1.2 mg $ L1 versus 3.9  9.0 mg $
L1, respectively (P ¼ .01). In patients with bidirectional
cavopulmonary anastomosis performed with CPB
(n ¼ 30), cTn-I<24h was slightly higher than in thosegery c December 2012
TABLE 2. Reclassification table
Non-T model T model
ReclassifiedPredicted risk <5% 5%-15% 15%-30% >30%
<5%
N 316 45 — — 12.4%
Meeting the composite outcome 9 1 Tetralogy of Fallot
1 MBT shunt
Observed risk 2.8% 4.4% — —
Risk predicted by the non-T model 2.9% 4.1%
Risk predicted by the T model 2.9% 8.1%
5%-15%
N 57 300 45 — 25.4%
Meeting the composite outcome 1 Tetralogy of Fallot
1 MBT shunt
27 3 ASO
1 ASOþVSD
1 TAPVC
1 MBT shunt
—
Observed risk 3.5% 9.0% 13.3% —
Risk predicted by the non-T model 6.3% 10.0% 11.3%
Risk predicted by the T model 4.1% 9.0% 20.0%
15%-30%
N — 57 86 19 46.9%
Meeting the composite outcome — 2 Truncus arteriosus
1 ASOþVSD
2 CAVC
1 Tetralogy of Fallot
1 PA banding
13 2 Truncus arteriosus
2 ALCAPA
1 ASO
1 ASOþVSD
1 HLHS procedure
1 TAPVC
1 Bidirectional
cavopulmonary
anastomosis
1 PA banding
Observed risk — 12.3% 15.3% 52.6%
Risk predicted by the non-T model 17.2% 21.1% 23.4%
Risk predicted by the T model 13.4% 20.4% 35.9%
>30%
N — — 14 84 14.3%
Meeting the composite outcome — — 1 ASOþVSD
1 Coarctation repair
1 CAVC
1 Aortic arch reconstruction
1 Aortic valvuloplasty
51
Observed risk — — 35.7% 60.7%
Risk predicted by the non-T model 33.8% 54.2%
Risk predicted by the T model 28.3% 54.9%
The reclassification table illustrates the proportion of improvements in reclassification (when a patient meeting the outcome moves up a risk category, and a patients not meeting
the outcome moves down) and the proportion of worse reclassification (when a patients meeting the outcome moves down a risk category and a patients not meeting the outcome
moves up). Only procedures performed in patients meeting the composite outcome are identified here. MBT, Modified Blalock-Taussig; ASO, arterial switch operation; VSD,
ventricular septal defect; TAPVC, total anomalous pulmonary venous connection; ALCAPA, anomalous origin of the left coronary artery from the pulmonary artery; CAVC, com-
plete atrioventricular canal; HLHS, hypoplastic left heart syndrome; PA, pulmonary artery.
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$ L1, respectively (P ¼ .15).
Figures 1 and 2 show all of the cTn-I concentrations re-
corded per procedure within the first week after surgery. To-
gether with the results in Table 1, they suggest that there
were several procedures in which the cTn-I concentrationThe Journal of Thoracic and Carpattern differed between patients with the composite out-
come and others: ASO, ASO plus VSD, truncus arteriosus
repair, HLHS procedures, and ALCAPA repair. Seven pa-
tients with ASO, whether with intramural or single coronary
arteries, had a peak cTn-I<24h of 16.7 15.6 mg $ L1 ver-
sus 9.0 7.4 mg $ L1 in others (P¼ .02). Two patients withdiovascular Surgery c Volume 144, Number 6 1441
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cardial infarction, were placed on ECMO, and died after
weaning from ECMO. Among patients undergoing truncus
arteriosus repair, 10 (58.8%) had coronary ostial or arterial
abnormalities and 9 had significant truncal valve regurgita-
ton. Six patients had both coronary abnormalities and valve
regurgitation; their peak cTn-I<24h was 57.0  24.3 mg $
L1 versus 28.5  14.2 mg $ L1 when only one or neither
of these abnormalities was present (P¼ .03). Of them, 5 pa-
tients met the composite outcome: two had extensive myo-
cardial infarction and had rescue ECMO; one survived and
the other died on day 4.
Variables used as predictors of the composite outcome in
the non-T model were: age, weight, the Aristotle score,
duration of CPB and crossclamping, the use of deep hypo-
thermic circulatory arrest, preoperative cardiac risk factors
(shock, cardiopulmonary resuscitation, ventricular or supra-
ventricular tachycardia), and preoperative pulmonary risk
factors (mechanical ventilation, pulmonary hypertension
owing to elevated pulmonary resistance, laryngobroncho-
tracheal malacia tracheostomy, pulmonary lymphangiecta-
sis) (all P<.001), preoperative renal risk factors (kidney
injury, hydronephrosis) (P ¼ .004), preoperative genetic
abnormalities (Down, Marfan, William-Beuren, Di George
syndrome, other chromosomal abnormalities), and preoper-
ative gastrointestinal risk factors (necrotizing enterocolitis,
hepatic dysfunction, Hishprung disease, duodenal atresia)
(both P ¼ .06). Both the non-T and the T models were
well calibrated (Hosmer-Lemeshow test, P ¼ .07 and .11,
respectively), and their c-indexes were 0.795 and 0.806,
respectively, showing good discrimination. The difference
between c-indexes was not significant (0.011 [0.004 to
0.029]), showing that the predictive ability of the non-T
model has not improved after including the high peak
cTn-I<24h as a predictor.
Reclassification is shown in Table 2. In 786 of 1023
(76.8%) patients, the T and non-T models predicted a simi-
lar risk. In the subgroup including ASO, ASO plus VSD,
truncus ateriosus, HLHS, and ALCAPA, 70 (28.6%) cases
were reclassified, of which 48 (68.6%) cases were reclassi-
fied correctly. Most reclassified cases were issued from the
intermediate risk categories, responding to physician’s ex-
pectations, interested in the reclassification of those for
whom treatment decisions are unclear. In the remaining
subgroup, 167 (21.5%) cases were reclassified, but only
84 (50.3%) were reclassified correctly, suggesting random
reclassification. Adding the high peak cTn-I<24h to the
non-T model did not improve the overall risk reclassifica-
tion and discrimination: the overall NRI was low
(NRI ¼ 0.06; P ¼ .22), both in cases meeting the outcome
(NRI¼ 0.03; P¼ .48) and in those not meeting the outcome
(NRI ¼ 0.02; P ¼ .11). The overall IDI was not significant
either (IDI ¼ 0.019; P ¼ .06). Both indexes showed signif-
icant improvement in reclassification and discrimination1442 The Journal of Thoracic and Cardiovascular Surwhen applied separately to the subgroup including ASO,
ASO plus VSD, truncus arteriosus, HLHS, and ALCAPA
(NRI ¼ 0.23; P ¼ .005; IDI ¼ 0.05; P<.001). After this
subgroup was excluded, there was no improvement in re-
classification and discrimination (NRI ¼ 0.03; P ¼ .56;
IDI ¼ 0.003; P ¼ .76).
DISCUSSION
Current data suggest the usefulness of serial troponin
measurements to identify adults who are at considerably in-
creased risk for complications after cardiac surgery and al-
low for more intensive monitoring and interventions proven
to increase survival.2-7 According to Croal and associates,6
a high cTn-I concentration within 18 to 24 hours of surgery
is the strongest independent predictor of the risk for death in
adults with cardiac surgery (odds ratio, 5.45; 95% confi-
dence interval, 4.5-232), in whom absolute levels of postop-
erative troponin correlate with the extent of myocardial
damage. A troponin T concentration within the upper quin-
tile has been found to be an independent predictor of myo-
cardial infarction, shock, and in-hospital death in adults,2
and a 10 mg $ L1 increase of cTn-I has been found to be
related to a 19% increased risk of 30-day mortality.6 Nev-
ertheless, confusion remains with regard to what is
a ‘‘high-risk’’ troponin concentration, and the threshold
for the prediction of short-term outcome differs after differ-
ent procedures in adults.7
The interpretation of troponin release after surgery for
congenital cardiac disease is complex. High concentrations
measured early after cardiac surgery in children have been
related to the occurrence of low cardiac output, need for
a delayed sternal closure, duration of inotropic support,
length of mechanical ventilation and LOS, severity of renal
impairment, and postoperative death.8-17 However, elevated
cTn-I concentrations are common, and it is conceivable that
a threshold level ofmyocardial damage, and thus a threshold
concentration of cTn-I, must occur before functional im-
pairment is manifested. The extent of postoperative tropo-
nin release in children has been shown to be associated
with young age, cyanosis, long bypass and crossclamping
durations, and ventriculotomy.13,14,16,30 The most
appropriate questions are whether a measured cTn-I con-
centration in a particular individual is higher than might
be expected when other factors are taken into account and
whether a high cTn-I concentration indicates that the patient
is at increased risk for complications.
The absolute value for a ‘‘high-risk’’ cTn-I concentration
after surgery for congenital cardiac disease has been the
subject of conflicting data. A cTn-I<24h concentration
above 35 mg $ L1 or a concentration above 25 mg L1 at 4
hours after admission in the ICU has been found to be asso-
ciated with long length of inotropic support or mechanical
ventilation and with severe kidney injury. A concentration
above 100 mg $ L1 has been associated with postoperativegery c December 2012
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patients, Mildh and colleagues14 found a troponin T con-
centration above 5.9 mg $ L1 to be an independent predictor
of 30-day death, with a 95% specificity and 30% sensitiv-
ity. However, several reports,9,12 including that by Mildh
and coworkers,14 have shown that the variation in troponin
release is lesion-specific, with concentrations more than
twofold higher in cases requiring ventriculotomy. As
such, the 75th percentile of troponin T concentration in pa-
tients with ventriculotomy was 4.8 mg $ L1 in the study by
Mildh and associates,14 explaining the low sensitivity of the
5.9 mg $ L11 threshold. Such findings point to the main lim-
itation of most pediatric studies, based on various case
mixes and small sample sizes: it may be that there is no uni-
versal cTn-I threshold and no universal ability to predict
outcome after various procedures for congenital cardiac dis-
ease. Combining procedures with various complexities may
lead to false associations between postoperative troponin
and outcome, probably biased by the association between
surgical complexity and outcome. Therefore, analysis of
homogeneous groups of surgical complexity appears
essential.
Peak cTn-I<24h was not a useful predictor of outcome af-
ter cardiac surgery in this case–mix population aged less than
1 year, except in a subgroup of patients undergoing ASO,
ASO plus VSD closure with or without aortic arch repair,
truncus arteriosus repair, HLHS procedures, or ALCAPA re-
pair, as shown by all of the statistical indexes used here. In
this subgroup of patients a high peak cTn-I<24h provided
the highest likelihood ratio for the composite outcome
(Table 1), reclassification was correct in a majority of cases
(Table 2), and the NRI and IDI were significant. Correct re-
classification of the risk category occurred in 48 (19.3%) pa-
tients in this subgroup, rendering the knowledge of the peak
cTn-I concentration useful for the physician. It occurred in
only 84 (10.8%) patients in the remaining group, in whom
the lack of usefulness of cTn-I is well illustrated by the large
peak recorded after uneventful common atrioventricular ca-
nal repairs, when compared with complicated ones (null sen-
sitivity and likelihood ratio).
The findings in the present study are consistent with pre-
vious reports showing associations between peak cTn-I and
longer durations of inotropic support, mechanical ventila-
tion, and LOS after ASO.12,32 The presence of intramural
or single coronary arteries associated with difficult
coronary transfer has been shown to be a major cause of
mortality after ASO.33 The present study found signifi-
cantly higher peak cTn-I<24h in patients with intramural
or single coronary arteries than in others, suggesting myo-
cardial ischemic injury as a determinant of mortality in
such cases.
In patients with truncus arteriosus, the incidence of coro-
nary artery anomalies is known to be high and to contribute
to the high operative mortality rate.22,34 Troponin releaseThe Journal of Thoracic and Carwas higher in patients with coronary anomalies and
truncal valve regurgitation in the present study. In patients
with ALCAPA, myocardial perfusion is dependent on the
collateral flow between the 2 coronary systems, and
occlusion of the pulmonary arteries during infusion of
cardioplegic solution is required to avoid steal through the
abnormal artery. Thus, in patients with truncus arteriosus
and ALCAPA, a suboptimal cardioplegic protection,
whether because of coronary abnormalities and truncal
valve regurgitation in truncus arterious or because of
insufficient collateral flow between the 2 coronary
systems in patients with ALCAPA, could have been the
cause of increased cTn-I release.
Patients with HLHS have reduced ventricular mass. Al-
though patients with HLHSwere expected to have large tro-
ponin release as a result of long CPB durations in the study
by Saraiya and colleagues,16 their cTn-I concentrations
were similar to those recorded in patients with ASO. Such
a result is consistent with the findings in the present report,
showing overall higher cTn-I<24h concentrations in pa-
tients with ASO when compared with those with HLHS,
and a large overlap between concentrations measured in pa-
tients with uneventful ASO (range, 2.5-23.7 mg $ L1) and in
patients with complicated HLHS procedures (range, 4.4-
39.8 mg $ L1) (Figure 1). Wemake the assumption that sim-
ilar myocardial injury was likely to result in significantly
more functional impairment and in an artificially increased
sensitivity of cTn-I in patients with HLHS.
Our results are consistent with previous findings
showing no usefulness of cTn-I monitoring after vascular
surgery.11,16
Limitations
The retrospective design of the present study requires that
the validity of our findings be considered with caution. All
cTn-I concentrations were available to the attending clini-
cians and may have prompted interventions that could
have influenced the outcome. The current study does not ad-
dress the important issue of the mechanism of cTn-I eleva-
tion. Finally, the variety and the lack of standardization of
the different cTn-I assays available, as well as the variety
of surgical techniques and patient–case mixes, do not allow
the absolute thresholds derived in the present study be uni-
versally applied. Instead, it is more appropriate for individ-
ual centers to establish their own thresholds on the basis of
local practices and analytical techniques.
CONCLUSIONS
Our findings suggest that, unlike in adults, routine mon-
itoring of cTn-I after surgery for congenital cardiac disease
is not useful in patients less than 1 year old. In this popula-
tion of neonates and infants, the cTn-I concentrations
measured within 24 hours of surgery were not predictive
of 30-day mortality and/or severe morbidity except indiovascular Surgery c Volume 144, Number 6 1443
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Ma subgroup of procedures with either a risk for inadequate
myocardial protection or perioperative myocardial infarc-
tion or in patients with reduced ventricular mass. This sub-
group included patients undergoing ASO, ASO plus VSD
closure with or without aortic arch repair, truncus arteriosus
repair, HLHS procedures, or ALCAPA repair, and they
should benefit from cTn-I monitoring after surgery.
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